Showing results (201-210 of 245) with videos related to

Sort By:
Pageof 25
Applied Optics|May 15, 2013
Empirical correction of thermal responses in the Solar Occultation for Ice Experiment nitric oxide measurements and initial data validation resultsDavid Gómez-Ramírez, John W C McNabb, James M Russell, et al.
Journal of Visualized Experiments : Jove|February 17, 2025
Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker DiscoveryGabriel Jakob Trauner, Dominika Bernath-Nagy, Melek Sükran Kalinyaprak, et al.
Clinical Breast Cancer|June 13, 2006
Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approachNava Siegelmann-Danieli, Vivek Khandelwal, G Craig Wood, et al.
Nano Letters|May 15, 2014
A multifunctional load-bearing solid-state supercapacitorAndrew S Westover, John W Tian, Shivaprem Bernath, et al.
The Journal of Chemical Physics|March 4, 2005
A 3000 K laboratory emission spectrum of waterPierre-François Coheur, Peter F Bernath, Michel Carleer, et al.
Cancer Treatment Reports|February 1, 1979
Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinomaR Kane, H Harvey, T Andrews, et al.
Scientific Reports|October 6, 2025
Linking habitat preferences and fitness across scales for a relict bird species of the southern AndesTomás A Altamirano, Fernando J Novoa, Zoltan Von Bernath, et al.
Synthetic Biology (Oxford, England)|February 7, 2022
Cofactor-independent RNA editing by a synthetic S-type PPR proteinKalia Bernath-Levin, Jason Schmidberger, Suvi Honkanen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2006
Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG studyM Baweja, V J Suman, T R Fitch, et al.
The Journal of Biological Chemistry|April 2, 2011
Phosphomimetic substitution of heterogeneous nuclear ribonucleoprotein A1 at serine 199 abolishes AKT-dependent internal ribosome entry site-transacting factor (ITAF) function via effects on strand annealing and results in mammalian target of rapamycin complex 1 (mTORC1) inhibitor sensitivityJheralyn Martin, Janine Masri, Cheri Cloninger, et al.
Pageof 25